Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1973 1
1975 2
1976 2
1977 8
1978 13
1979 38
1980 16
1981 15
1982 22
1983 23
1984 18
1985 19
1986 17
1987 22
1988 19
1989 15
1990 15
1991 13
1992 15
1993 16
1994 15
1995 12
1996 10
1997 16
1998 15
1999 18
2000 15
2001 19
2002 14
2003 10
2004 18
2005 25
2006 20
2007 19
2008 19
2009 18
2010 24
2011 26
2012 43
2013 42
2014 62
2015 57
2016 51
2017 58
2018 56
2019 67
2020 81
2021 65
2022 71
2023 68
2024 21

Text availability

Article attribute

Article type

Publication date

Search Results

1,249 results

Results by year

Filters applied: . Clear all
Page 1
Clobazam monotherapy for focal or generalized seizures.
Arya R, Giridharan N, Anand V, Garg SK. Arya R, et al. Cochrane Database Syst Rev. 2018 Jul 11;7(7):CD009258. doi: 10.1002/14651858.CD009258.pub3. Cochrane Database Syst Rev. 2018. PMID: 29995989 Free PMC article. Review.
There was low-quality evidence that clobazam led to better retention compared with phenytoin (RR 1.43, 95% CI 1.08 to 1.90). ...AUTHORS' CONCLUSIONS: We found no advantage for clobazam over carbamazepine for retention at 12 months in drug-naive children and a slight …
There was low-quality evidence that clobazam led to better retention compared with phenytoin (RR 1.43, 95% CI 1.08 to 1.90). ...AUTHO …
Clobazam.
Ng YT, Collins SD. Ng YT, et al. Neurotherapeutics. 2007 Jan;4(1):138-44. doi: 10.1016/j.nurt.2006.11.002. Neurotherapeutics. 2007. PMID: 17199029 Free PMC article. Review.
This review will explore the use of clobazam in the treatment of epilepsy, particularly with regard to its potential benefit in LGS. ...A phase 2 study will be completed in late 2006 to investigate the safety and efficacy of clobazam as adjunctive therapy in 68 pedi …
This review will explore the use of clobazam in the treatment of epilepsy, particularly with regard to its potential benefit in LGS. …
Corticosteroids versus clobazam in epileptic encephalopathy with ESES: a European multicentre randomised controlled clinical trial (RESCUE ESES*).
van den Munckhof B, Arzimanoglou A, Perucca E, van Teeseling HC, Leijten FSS, Braun KPJ, Jansen FE; RESCUE ESES study group. van den Munckhof B, et al. Trials. 2020 Nov 23;21(1):957. doi: 10.1186/s13063-020-04874-2. Trials. 2020. PMID: 33228736 Free PMC article. Clinical Trial.
Based on mostly small and retrospective studies, corticosteroids and clobazam are regarded by many clinicians as the most effective pharmacological treatments. This European multicentre randomised controlled trial is designed to compare the effects of corticosteroids and …
Based on mostly small and retrospective studies, corticosteroids and clobazam are regarded by many clinicians as the most effective p …
Clobazam for treatment of epilepsy.
Giarratano M, Standley K, Benbadis SR. Giarratano M, et al. Expert Opin Pharmacother. 2012 Feb;13(2):227-33. doi: 10.1517/14656566.2012.647686. Epub 2012 Jan 13. Expert Opin Pharmacother. 2012. PMID: 22242724 Review.
With this paper, readers will gain a better understanding of the limits of Lennox-Gastaut syndrome and how it evolves with age and what clobazam can contribute to its treatment. EXPERT OPINION: Clobazam offers a new treatment option for patients with refractory epil …
With this paper, readers will gain a better understanding of the limits of Lennox-Gastaut syndrome and how it evolves with age and what c …
Clobazam monotherapy for partial-onset or generalized-onset seizures.
Arya R, Anand V, Garg SK, Michael BD. Arya R, et al. Cochrane Database Syst Rev. 2014 Oct 4;(10):CD009258. doi: 10.1002/14651858.CD009258.pub2. Cochrane Database Syst Rev. 2014. PMID: 25280512 Updated. Review.
There was low quality evidence that clobazam led to better retention compared with phenytoin (RR 1.43, 95% CI 1.08 to 1.90). ...AUTHORS' CONCLUSIONS: We found no advantage for clobazam over carbamazepine for retention at 12 months in drug-naive children and a slight …
There was low quality evidence that clobazam led to better retention compared with phenytoin (RR 1.43, 95% CI 1.08 to 1.90). ...AUTHO …
Clobazam: A Safe, Efficacious, and Newly Rediscovered Therapeutic for Epilepsy.
Gauthier AC, Mattson RH. Gauthier AC, et al. CNS Neurosci Ther. 2015 Jul;21(7):543-8. doi: 10.1111/cns.12399. Epub 2015 Apr 28. CNS Neurosci Ther. 2015. PMID: 25917225 Free PMC article. Review.
Clobazam is an oral 1,5-benzodiazepine used worldwide for the treatment of many types of epilepsies, although it is currently only approved for Lennox-Gastaut syndrome in the USA. ...Efficacy tolerance has not been a problem in the best studies. Clobazam has provide …
Clobazam is an oral 1,5-benzodiazepine used worldwide for the treatment of many types of epilepsies, although it is currently only ap …
Clobazam for patients with Lennox-Gastaut syndrome and epilepsy.
Seif-Eddeine H, Ng YT. Seif-Eddeine H, et al. Expert Rev Neurother. 2012 Apr;12(4):385-93. doi: 10.1586/ern.12.14. Expert Rev Neurother. 2012. PMID: 22449211 Review.
This article will explore the use of clobazam in the treatment of LGS and present the results of Phase II and III studies, along with an overall summary of the treatment of LGS, as well as the possible role of clobazam in a treatment algorithm. We based this article …
This article will explore the use of clobazam in the treatment of LGS and present the results of Phase II and III studies, along with …
Cenobamate and Clobazam Combination as Personalized Medicine in Autoimmune-Associated Epilepsy With Anti-Gad65 Antibodies.
Serrano-Castro PJ, Rodríguez-Uranga JJ, Cabezudo-García P, García-Martín G, Romero-Godoy J, Estivill-Torrús G, Ciano-Petersen NL, Oliver B, Ortega-Pinazo J, López-Moreno Y, Aguilar-Castillo MJ, Gutierrez-Cardo AL, Ramírez-García T, Sanchez-Godoy L, Carreño M. Serrano-Castro PJ, et al. Neurol Neuroimmunol Neuroinflamm. 2023 Aug 22;10(6):e200151. doi: 10.1212/NXI.0000000000200151. Print 2023 Nov. Neurol Neuroimmunol Neuroinflamm. 2023. PMID: 37607753 Free PMC article.
The mean follow-up was 156.75 days (SD = 68.23). In patients with concomitant treatment with clobazam (CLB), the median percentage of seizure reduction was higher than those not taking CLB: 94.72% (IQR: 87.25-100) vs 41.50% (p = 0.044) and also higher than the control grou …
The mean follow-up was 156.75 days (SD = 68.23). In patients with concomitant treatment with clobazam (CLB), the median percentage of …
Clobazam : in patients with Lennox-Gastaut syndrome.
Yang LP, Scott LJ. Yang LP, et al. CNS Drugs. 2012 Nov;26(11):983-91. doi: 10.1007/s40263-012-0007-0. CNS Drugs. 2012. PMID: 23034582 Review.
Clobazam, as with other benzodiazepines, has a long history of use in the treatment of epilepsy. ...Treatment with adjunctive clobazam was generally well tolerated in these clinical trials and after at least 2 years of treatment in an open-label extension study. ...
Clobazam, as with other benzodiazepines, has a long history of use in the treatment of epilepsy. ...Treatment with adjunctive clob …
A Comprehensive Overview of the Clinical Pharmacokinetics of Clobazam.
Tolbert D, Larsen F. Tolbert D, et al. J Clin Pharmacol. 2019 Jan;59(1):7-19. doi: 10.1002/jcph.1313. Epub 2018 Oct 4. J Clin Pharmacol. 2019. PMID: 30285275 Free PMC article. Review.
Clobazam (CLB) is a 1,5-benzodiazepine that has been widely used as an anxiolytic and antiseizure drug (ASD) since it was first synthesized over 50 years ago. ...
Clobazam (CLB) is a 1,5-benzodiazepine that has been widely used as an anxiolytic and antiseizure drug (ASD) since it was first synth …
1,249 results